Patrik Georgii-Hemming is Chief Medical Information Officer at Karolinska University Hospital.

Executive Advisor, PhD Danish Regions, Ph.D. in Science and Technology Studies and a Master Degree of Biochemistry.

Is involved in Genome Medicine Sweden projektet i AP2 Infrastruktur & informatic.

Mohsen Shadidi, Head of Section for Molecular Pathology, Department of Pathology, Oslo University Hospital

Dr. Léon van Kempen is a Clinical Scientist in Molecular Pathology at the department of Pathology, University Medical Center Groningen,

Anna Martling is a Professor of Surgery at Karolinska Institutet, Stockholm, Sweden.

Leon du Toit has over 10 years’ experience in developing IT solutions. Speaker at P{recision Medicine Forum 2022

Tobias Sjöblom, Professor in Tumor Genetics at Uppsala University, Sweden.

Professor Dame Sue Hill is the Chief Scientific Officer for England. Sue works across the health …

Tuuli Lappalainen, PhD, Professor at KTH Royal Institute of Technology.

Oncologist, Oslo University Hospital, Head of Research, Oslo Comprehensive Cancer Center, OUS, Professor University of Oslo, Norway

Carolina Donnerin is an innovation and project manager at RISE. Her background includes international experience of healthcare transformation and digital innovation.

Kári Stefánsson, M.D., Dr. Med. is founder and CEO of Reykjavik-based deCODE genetics. In Iceland

Cindy is Global Director of Population Health (Olink), speaker at Nordic PMF 2022.

Malin Eklund has a PhD in biotechnology from the Royal Institute of Technology, KTH in Stockholm Sweden.

Neeme Tõnisson is a Professor of Clinical Genetics and group leader in the Institute of Genomics, Univ. of Tartu / Estonian Biobank

Asif Jan joined Owkin from Roche where he was Global Head of Analytics (Personalised Healthcare) in the Pharma Product Development division.

Ebba Hallersjö Hult, Co-founder and Head of the Innovation Milieus Vision Zero Cancer

Mattias Rantalainen leads the Predictive Medicine group at Department of Medical Epidemiology and Biostatistics at Karolinska Institute in Sweden.

Agneta Larhed, PhD, senior pharmaceutical consultant, OnDosis, Mölndal, Sweden and RegSmart, Uppsala, Sweden

Mathieu completed his training with a PhD in Deep Learning and Signal Processing at PSL university and ENS Paris.

Anagha Joshi is a Professor in Bioinformatics at the faculty of medicine at the University of Bergen since 2018.

Thorunn Rafnar is the Head of Oncology at Reykjavik-based deCODE genetics. She received a Ph.D. degree at the University of North Carolina in 1990

Chris Wigley is the CEO of Genomics England, which exists to push insights from cutting edge genomics data analytics into routine medical care.

Prof. Andres Metspalu, Head of the Estonian Biobank, Institute of Genomics, University of Tartu.

Thorben Seeger is the mastermind behind Lifebit’s international commercial operations.

Head of Systems Medicine at Steno Diabetes Center Copenhagen and an Associate Professor at King’s College London.

Zsolt Illes MD, PhD is a professor at the University of Southern Denmark (Institute of Clinical Research, BRIDGE and Institute of Molecular Medicine).

Per B. Andersen, based in Copenhagen has 15 years of experience with Diagnostic testing pathways and assays.

Sebastian graduated from HEC Paris and Ecole polytechnique with a double degree in Data Science for Business.

Professor of Medicine at University of Oslo in 2001 and since 2018 served as Head of the Institute of Cancer Research, Oslo University Hospital

Judith Kairies is experienced within regulatory affairs and quality assurance in the life science industry.

Senior Ministerial Advisor, Ministry of Social Affairs and Health, Finland

Professor of bioinformatics at Uppsala University, Director of NBIS (National Bioinformatics Infrastructure Sweden, the SciLifeLab Bioinformatics platform)

Legal counsel at Sahlgrenska University Hospital since 2015. In 2020 she started to work for Genomic Medicine Sweden

Peter is Co-founder and Project Director MEGALIT. Director Department of Anestethic and Intensive Care, Region Örebro Län, Örebro, Sweden

Annika has been with Devyser since 2015, first as Technical Lead at R&D department and since June 2021 as Product Manager

Margareta Haag, Chair, Swedish Network Against Cancer

PhD in Biophysics from Cornell University. Professor of Medicine with Specialization in Systems Medicine at Örebro University

Head, Section for experimental pathology and Research Support, Dept. of Pathology, Oslo University Hospital, Norway

Nils J. Færgeman, Professor and Director of the molecular metabolism and metabolomics unit at the University of Southern Denmark

Päivi Östling has more than 10 years of research experience in the field of precision cancer medicine (PCM) research.

Head of International Affairs at Oslo Cancer Cluster, is a life science professional with more than 20 years of industry experience.

Steve Williams is currently responsible for Clinical R&D, Medical Affairs and Regulatory and Quality.

Per-Johan Jakobsson, Consultant Rheumatologist and Professor in Translational Inflammation Research

Grethe S. Foss is Senior Adviser and Project Leader for personalised medicine at the Norwegian Directorate of Health.

Bettina Ryll, MD/PhD works as subject expert for personalised medicine for Vision Zero Cancer

Anna Wedell, MD, PhD, Professor at Karolinska Institutet and Senior Consultant at the Centre for Inherited Metabolic Diseases

Nick has over 20 years experience in regulatory affairs for IVD’s first at the British Standards Institute and then at Lloyd’s Register Quality Assurance (LRQA)

Merike Leego, MBA, MSc, is Innovation Manager at EIT Health Scandinavia, the European Commission funded network.

Mattias Paulsson, PhD, Deputy chief pharmacist, Uppsala University Hospital, Sweden

Maria Pernemalm, Assistant Professor, Department of Oncology and Pathology at Karolinska Institutet

Seppo Vainio is a professor of developmental biology at the University of Oulu, Finland.

Dr Wessman holds a position as Principal Scientist in product development and formulation.